SVB Leerink Analysts Cut Earnings Estimates for agilon health, inc. (NYSE:AGL)

agilon health, inc. (NYSE:AGL – Get Rating) – SVB Leerink lowered their Q1 2023 earnings per share (EPS) estimates for agilon health in a research report issued on Thursday, March 2nd. SVB Leerink analyst W. Mayo now expects that the company will earn $0.05 per share for the quarter, down from their previous forecast of $0.06. SVB Leerink currently has a “Outperform” rating and a $30.00 target price on the stock. The consensus estimate for agilon health’s current full-year earnings is $0.01 per share. SVB Leerink also issued estimates for agilon health’s Q2 2023 earnings at $0.04 EPS, FY2023 earnings at $0.05 EPS, Q4 2024 earnings at $0.03 EPS, FY2024 earnings at $0.31 EPS, FY2025 earnings at $0.59 EPS, FY2026 earnings at $1.00 EPS and FY2027 earnings at $1.53 EPS.

Other equities research analysts also recently issued reports about the company. Deutsche Bank Aktiengesellschaft upped their target price on agilon health from $26.00 to $28.00 in a report on Friday. Wells Fargo & Company reduced their price objective on agilon health from $28.00 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, November 15th. Stifel Nicolaus started coverage on agilon health in a research note on Thursday, December 8th. They issued a “buy” rating and a $23.00 price objective for the company. Finally, The Goldman Sachs Group reduced their price objective on agilon health from $38.00 to $34.00 and set a “buy” rating for the company in a research note on Tuesday, November 15th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, agilon health currently has a consensus rating of “Moderate Buy” and an average target price of $28.63.

agilon health Trading Up 3.1 %

Shares of NYSE AGL opened at $25.22 on Friday. agilon health has a 12 month low of $14.82 and a 12 month high of $28.36. The company has a market cap of $10.39 billion, a price-to-earnings ratio of -97.00 and a beta of 1.09. The company has a quick ratio of 2.48, a current ratio of 2.48 and a debt-to-equity ratio of 0.04. The business has a fifty day simple moving average of $20.31 and a 200-day simple moving average of $20.21.

Insiders Place Their Bets

In other agilon health news, insider Benjamin Kornitzer sold 2,698 shares of the company’s stock in a transaction dated Thursday, January 5th. The stock was sold at an average price of $15.51, for a total value of $41,845.98. Following the transaction, the insider now directly owns 10,426 shares of the company’s stock, valued at approximately $161,707.26. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other agilon health news, insider Benjamin Kornitzer sold 2,698 shares of the company’s stock in a transaction dated Thursday, January 5th. The stock was sold at an average price of $15.51, for a total value of $41,845.98. Following the transaction, the insider now directly owns 10,426 shares of the company’s stock, valued at approximately $161,707.26. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Benjamin Shaker sold 28,555 shares of the stock in a transaction dated Wednesday, February 15th. The shares were sold at an average price of $23.37, for a total value of $667,330.35. Following the transaction, the insider now directly owns 25,625 shares in the company, valued at approximately $598,856.25. The disclosure for this sale can be found here. Insiders have sold a total of 68,168 shares of company stock valued at $1,413,444 in the last three months. Insiders own 3.30% of the company’s stock.

Hedge Funds Weigh In On agilon health

Institutional investors have recently modified their holdings of the company. Yarger Wealth Strategies LLC raised its position in shares of agilon health by 20.5% in the third quarter. Yarger Wealth Strategies LLC now owns 163,877 shares of the company’s stock valued at $3,838,000 after purchasing an additional 27,876 shares during the period. Vontobel Holding Ltd. bought a new position in shares of agilon health in the third quarter valued at approximately $803,000. Summit Financial Strategies Inc. bought a new position in shares of agilon health in the third quarter valued at approximately $780,000. Level Financial Advisors Inc. bought a new position in shares of agilon health in the second quarter valued at approximately $289,000. Finally, TriaGen Wealth Management LLC bought a new position in shares of agilon health in the third quarter valued at approximately $296,000.

About agilon health

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.